Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial
Top Cited Papers
- 1 September 2004
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 364 (9437), 849-857
- https://doi.org/10.1016/s0140-6736(04)16980-8
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Combined endpoints: can we use them?Statistics in Medicine, 2002
- Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trialThe Lancet, 2002
- Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trialsThe Lancet, 2000
- Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT)The Lancet, 2000
- Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk PatientsNew England Journal of Medicine, 2000
- Effect of long-acting and short-acting calcium antagonists on cardiovascular outcomes in hypertensive patientsThe Lancet, 1997
- Total Ischaemic Burden European Trial (TIBET): Effects of ischaemia and treatment with atenolol, nifedipine SR and their combination on outcome in patients with chronic stable anginaEuropean Heart Journal, 1996
- NifedipineCirculation, 1995
- Nifedipine and MortalityCirculation, 1995
- The Calcium Channel Blocker ScareCirculation, 1995